3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Glioblastoma
2
Spondylitis, Ankylosing
1
Signs and Symptoms
1
Psoriasis
1
Nutrition Disorders
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Insulin Resistance
1
Inflammatory Bowel Diseases
1
Glioma
1
Gastroparesis
1
Feeding and Eating Disorders
1
Esophageal Neoplasms
1
Epilepsy
1
Dumping Syndrome
1
Diarrhea
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Metformin
28
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
5
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Surveys and Questionnaires
2
Sugars
2
Resistance Training
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Caloric Restriction
2
ziprasidone
1
maltodextrin
1
lime
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
adrenosterone
1
World Health Organization oral rehydration solution
1
Waist-Hip Ratio
1
Waist Circumference
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Insulin Resistance
×
Sulfasalazine
×
Clear all
NCT03734627
2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
40 enrolled